|
Antibiotics and resistance |
AMR-human |
January 1, 1960 |
|
Bacterial diseases |
|
|
National reference center for bacterial meningitis and gastrointestinal diseases |
NRC bactMeng&gastro |
January 1, 1960 |
|
Bacterial diseases |
|
|
Network of General Practitioners |
SGPs |
January 1, 1979 |
|
Health services research, Epidemiology of infectious diseases |
surveillance, sentinel, general practice |
|
Surveillance of pollen and fungal spores in the outdoor air in Belgium |
AirAllergy |
January 1, 1982 |
|
Mycology and aerobiology |
pollen, rhinitis, allergy |
|
National Reference Center for tuberculosis and mycobacteria |
NRC Tuberc&myco |
January 1, 1990 |
|
Bacterial diseases |
|
|
Assessment of the toxicity of pesticides for agricultural use at national and international level |
PESTBIONAT & PESTINT |
January 2, 1990 |
|
Risk and health impact assessment |
pesticides, plant protection products, toxicity, hazard and risk assessment |
|
Belgian contribution to the international Orphanet portal for rare diseases and orphan drugs |
OrphanetBelgium |
January 1, 1997 |
|
Health services research |
rare diseases and disorders, orphan drugs, database, world wide web, availability of Health Services |
|
Initiative for Quality improvement and Epidemiology in Diabetes |
IQED |
November 7, 2001 |
|
Health services research |
|
|
Network of pediatric infectious disease surveillance |
PediSurv |
October 1, 2002 |
|
Epidemiology of infectious diseases |
|
|
National Food Consumption Survey |
FCS |
January 1, 2004 |
|
Lifestyle and chronic diseases |
food consumption, usual intake, fat, sugar, carbohydrates, proteins, energy, vitamins, minerals, salt, iodine, guidelines |
|
Exposure Risk Assessments |
ERA |
January 1, 2004 |
|
Lifestyle and chronic diseases |
food, additives, contaminants, exposure, risk assesment |
|
Belgian Cystic Fibrosis Registry |
BCFR |
October 1, 2006 |
|
Health services research |
Cystic fibrosis, Registry, Quality of care |
|
Belgian neuromuscular diseases registry |
BNMDR |
January 1, 2008 |
|
Health services research |
neuromuscular diseases, register |
|
Initiative for Quality Improvement and Epidemiology in Children and Adolescents with Diabetes |
IQECAD |
February 1, 2009 |
|
Health services research |
Diabetes, diabetes care, diabetic children, diabetic adolescents, young diabetic patients, quality improvement, audit-feedback |
|
Diagnosis-Based Morbidity Statistics |
MORBISTAT |
April 1, 2010 |
|
Lifestyle and chronic diseases |
population health monitoring, morbidity |
|
Intradermal rabies vaccination trials in humans: towards shorter and cheaper rabies vaccination |
Intradermo |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, intradermal vaccination, clinical trials |
|
Quality indicators for infection prevention and control in acute hospitals |
NSIH_QI |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
quality indicators, infection prevention and control, acute hospitals |
|
National Reference Laboratory/Centre for Rabies: surveillance and diagnosis of rabies in man and animal |
NRL/NRC Rabies |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, lyssavirus, bats, diagnosis, serology, surveillance |
|
Clinical Biology LMM |
LMM |
June 1, 2011 |
|
Infectious diseases in humans, Laboratory of medical microbiology (LMM) |
Laboratory, Medical Microbiology, clinical biology, test validation, quality control, communication improvement, clinical relevance optimisation, medical collaboration, medical contacts, Belgian Communities, medical expert advice |
|
Central Registry Rare Diseases |
CRRD |
January 1, 2012 |
|
Health services research |
patient registry, rare diseases, epidemiology, genetic centre, ORPHA-code, Healthdata.be, clinical trial recruitment, common data set |
|
Communication with communities |
Communication with communities |
January 2, 2012 |
|
Infectious diseases in humans, Laboratory of medical microbiology (LMM) |
Laboratory, Medical Microbiology, Belgian Communities, infectious diseases, medical advice, logistical support, sample management, data on infectious diseases |
|
Bioavailability and transformation of arsenic from food: role of food preparation, preservation and digestion |
BIOTRAs |
February 1, 2012 |
January 31, 2015 |
Trace elements and nanomaterials |
arsenic, speciation, bioaccessibility, risk evaluation, exposure, food preparation |
|
Virus-host interplay at the early stages of infection |
BELVIR |
October 1, 2012 |
September 30, 2017 |
Trace elements and nanomaterials |
myxoviruses, glycoproteins, TEM, attachment-fusion, mucus, GFP |
|
The Orphanet Encyclopedia, Terminology and Website in Dutch |
OrphaDutch |
January 1, 2013 |
|
Health services research |
rare diseases and disorders, orphan drugs, world wide web, accessibility of Health Services, terminology, Snomed-CT, nomenclature, disease coding |
|
A common European approach to the regulatory testing of Manufactured Nanomaterials |
NANoREG |
March 1, 2013 |
February 28, 2017 |
Trace elements and nanomaterials |
nanomaterials, EC definition, TEM, inter laboratory comparison, SOP validation |
|
Improvement of anti-TB treatment by study of antibiotic resistance mechanisms |
TB drugs |
June 24, 2013 |
|
Bacterial diseases |
mycobacterium tuberculosis, antibiotic resistance, genetic changes, protein structure, mutants, DNA sequencing |
|
Belgian Bioelectromagnetics Group |
ELIA2 |
July 1, 2013 |
July 1, 2017 |
Risk and health impact assessment |
electromagnetic fields, Alzheimer’s disease, genetic effects, project coordination, BBEMG |
|
Tick-borne encephalitis virus eco-epidemiology: study of the prevalence and pathogenesis in rodents and wild animals |
TBEV Epi |
October 1, 2013 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases, Quality of vaccines and blood products |
tick-borne encephalitis virus, ticks, sentinel, seroprevalence, rodents |
|
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe |
ADVANCE |
October 1, 2013 |
September 30, 2018 |
Epidemiology of infectious diseases, Quality of vaccines and blood products |
vaccination, immunisation, preventive, therapeutical, pharmacovigilance, epidemiology, surveillance, risk/benefit assesment, patients |
|
Use of proteomics for the quality control of intravenous immunoglobulins |
PLPROT |
October 1, 2013 |
September 30, 2017 |
Quality of vaccines and blood products |
proteomics, quality control, immunoglobulins, plasma derivatives |
